Source: Mediators of Inflammation. Unidades: ICB, FM
Subjects: FISIOLOGIA, LIPOPOLISSACARÍDEOS, EXPRESSÃO GÊNICA, MACRÓFAGOS, COLESTEROL, REAÇÃO EM CADEIA POR POLIMERASE, ARTERIOSCLEROSE, CITOCINAS
ABNT
OKUDA, Ligia Shimabukuro et al. Advanced glycated apoA-IV loses its ability to prevent the LPS-induced reduction in cholesterol efflux-related gene expression in macrophages. Mediators of Inflammation, v. 2020, p. 11 , 2020Tradução . . Disponível em: https://doi.org/10.1155/2020/6515401. Acesso em: 15 nov. 2024.APA
Okuda, L. S., Iborra, R. T., Pinto, P. R., Machado, U. F., Giannella, M. L. C. C., Pickford, R., et al. (2020). Advanced glycated apoA-IV loses its ability to prevent the LPS-induced reduction in cholesterol efflux-related gene expression in macrophages. Mediators of Inflammation, 2020, 11 . doi:10.1155/2020/6515401NLM
Okuda LS, Iborra RT, Pinto PR, Machado UF, Giannella MLCC, Pickford R, Woods T, Brimble MA, Rye K-A, Passarelli M. Advanced glycated apoA-IV loses its ability to prevent the LPS-induced reduction in cholesterol efflux-related gene expression in macrophages [Internet]. Mediators of Inflammation. 2020 ; 2020 11 .[citado 2024 nov. 15 ] Available from: https://doi.org/10.1155/2020/6515401Vancouver
Okuda LS, Iborra RT, Pinto PR, Machado UF, Giannella MLCC, Pickford R, Woods T, Brimble MA, Rye K-A, Passarelli M. Advanced glycated apoA-IV loses its ability to prevent the LPS-induced reduction in cholesterol efflux-related gene expression in macrophages [Internet]. Mediators of Inflammation. 2020 ; 2020 11 .[citado 2024 nov. 15 ] Available from: https://doi.org/10.1155/2020/6515401